GIDARI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 706
EU - Europa 510
AS - Asia 468
SA - Sud America 99
AF - Africa 8
OC - Oceania 3
Totale 1.794
Nazione #
US - Stati Uniti d'America 688
SG - Singapore 212
IT - Italia 207
HK - Hong Kong 94
IE - Irlanda 90
BR - Brasile 87
CN - Cina 66
DE - Germania 56
RU - Federazione Russa 42
KR - Corea 37
FI - Finlandia 29
VN - Vietnam 25
GB - Regno Unito 18
AT - Austria 13
FR - Francia 12
CA - Canada 9
IN - India 9
MX - Messico 8
LT - Lituania 6
NL - Olanda 6
ID - Indonesia 5
JP - Giappone 5
PL - Polonia 5
AR - Argentina 4
BE - Belgio 4
CZ - Repubblica Ceca 4
SE - Svezia 4
UA - Ucraina 4
ZA - Sudafrica 4
ES - Italia 3
AU - Australia 2
CH - Svizzera 2
EC - Ecuador 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
GF - Guiana Francese 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MR - Mauritania 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
TR - Turchia 1
UZ - Uzbekistan 1
VE - Venezuela 1
WS - Samoa 1
Totale 1.794
Città #
Singapore 126
Perugia 108
Chandler 99
Hong Kong 94
Dublin 90
Ashburn 55
Boardman 39
Seoul 36
Munich 33
Santa Clara 33
Los Angeles 31
New York 24
Columbus 22
San Mateo 20
Redmond 19
Turku 18
Wilmington 17
Moscow 15
Altamura 13
Piscataway 13
Medford 12
Princeton 12
Ho Chi Minh City 11
Lawrence 11
São Paulo 10
Dallas 9
Milan 9
Ann Arbor 8
Bastia umbra 8
Bologna 8
Florence 8
Hanoi 8
Nuremberg 8
Rome 8
Beijing 7
Helsinki 7
Poplar 7
Vienna 6
Chennai 5
Falkenstein 5
Hefei 5
Mexico City 5
Montreal 5
Padova 5
Paris 5
The Dalles 5
Tokyo 5
Warsaw 5
Andover 4
Boston 4
Brooklyn 4
Brussels 4
Denver 4
Lappeenranta 4
Atlanta 3
Belo Horizonte 3
Den Haag 3
Des Moines 3
Frankfurt am Main 3
Houston 3
Manchester 3
Mumbai 3
Seattle 3
Stockholm 3
Tappahannock 3
Toronto 3
Chengdu 2
Chicago 2
Falls Church 2
Guangzhou 2
Juiz de Fora 2
London 2
Madrid 2
Manaus 2
Naples 2
Oklahoma City 2
Olomouc 2
Orem 2
Phoenix 2
Porto Alegre 2
Querétaro 2
Recife 2
Rio de Janeiro 2
San Jose 2
Santos 2
Sinalunga 2
St Petersburg 2
Vicenza 2
Vilnius 2
West Jordan 2
Woodbridge 2
Alcamo 1
Amsterdam 1
Anguillara Sabazia 1
Ankara 1
Annapolis 1
Apia 1
Arantina 1
Araucária 1
Araçatuba 1
Totale 1.231
Nome #
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 123
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 118
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 92
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 91
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 89
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 83
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 83
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 79
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 75
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 72
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 71
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 69
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 64
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 64
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 62
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 60
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 52
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 51
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 51
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 51
Nelfinavir: An Old Ally in the COVID-19 Fight? 50
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 49
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 49
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 46
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 44
Chronic antibiotic suppressive therapy with dalbavancin: a case series 42
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 39
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 36
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 29
Totale 1.884
Categoria #
all - tutte 9.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 7 3 1 2 2 19 1 17
2021/2022108 6 19 3 2 4 5 1 17 7 6 24 14
2022/2023328 12 45 5 49 29 26 3 15 122 0 17 5
2023/2024184 7 21 5 2 4 4 57 1 12 11 30 30
2024/2025664 15 42 19 32 35 46 92 65 102 58 97 61
2025/2026529 71 89 63 199 107 0 0 0 0 0 0 0
Totale 1.884